Experts Urge FDA To Define Key Terms In Upcoming Guidance On AI Use

By Maaisha Osman / April 8, 2024 at 4:14 PM

As FDA’s drug center gears up to issue guidance on use of artificial intelligence to enhance its regulatory decision-making, industry experts are urging the agency to provide explicit definitions for the terms "safe," "responsible," and "ethical" use of AI rather than leaving the terms open for interpretation.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.